FasterCures

Dentons Global Advisors-ASG and MITRE to Sponsor ACRES Health-Science System Design Initiative at the National Academy of Medicine

Retrieved on: 
Thursday, December 8, 2022

BOSTON, Dec. 8, 2022 /PRNewswire-PRWeb/ -- The Alliance for Clinical Research Excellence and Safety (ACRES) announced today that Dentons Global Advisors-Albright Stonebridge Group (ASG) and MITRE are sponsoring SYNERGY 2022, a unique exercise to envision a comprehensive integrated system for the future-state of health and science through application of systems-thinking and systems engineering principles.

Key Points: 
  • SYNERGY 2022, ACRES Health-Science System Design Initiative at the National Academy of Medicine to envision a comprehensive integrated system for the future of health and science using systems-thinking and systems engineering principles, is being sponsored by Dentons Global Advisors-ASG and MITRE.
  • ACRES, together with our partner organizations, FasterCures and MITRE, have launched an initiative to change the way we think about health and science in a more systematic way, and our sponsors, Dentons Global Advisors-ASG and MITRE, are making it possible."
  • The SYNERGY 2022 event, being hosted by the National Academy of Medicine, was previously announced by ACRES last month.
  • The event convenes on December 12-13 at the National Academy of Sciences, Engineering and Medicine in Washington, DC.

National Academy of Medicine to Host SYNERGY Event Aimed at Envisioning a Future HealthScience System

Retrieved on: 
Tuesday, November 1, 2022

BOSTON, Nov. 1, 2022 /PRNewswire-PRWeb/ -- SYNERGY 2022 is the third event in a series of 'systems-thinking' exercises convened by ACRES since its founding in 2012, and the most ambitious to date. Together with its partner organizations, the MITRE Corporation and FasterCures, ACRES is bringing together a select group of 60 leaders and innovators from health, business, government, technology, academia, and patient groups to apply systems-thinking and systems engineering principles to envision a new integrated approach to health and science in the US. Our goal is to create a truly enterprise-wide system that uses advanced technologies and analytics to achieve levels of quality, safety, efficiency, and effectiveness that have not previously been possible in health and science.

Key Points: 
  • The Alliance for Clinical Research Excellence and Safety (ACRES) announced today that the National Academy of Medicine will host a special systems event, SYNERGY 2022, to convene at the National Academies of Sciences, Engineering and Medicine on December 12-13, 2022 in Washington, DC.
  • The vision is now clearer, but advances in practical execution depend up on the sorts of discussions anticipated at SYNERGY 2022."
  • SYNERGY 2022's two-day working exercise in systems thinking seeks to envision and draft a blueprint for an "Intelligent HealthScience System".
  • ACRES, The National Academy of Medicine, MITRE Corporation, and The Milken Institute are 501(c)(3) non-profit organizations operating in the public interest.

Milken Institute Outlines Next Steps for Mobilizing an Early Warning System for Pandemics

Retrieved on: 
Wednesday, March 30, 2022

A Global Early Warning System for Pandemics: A Blueprint for Coordination outlines governance, data, financing, and incentive considerations for creating an early warning system.

Key Points: 
  • A Global Early Warning System for Pandemics: A Blueprint for Coordination outlines governance, data, financing, and incentive considerations for creating an early warning system.
  • Global health experts from academia, finance, nonprofit, philanthropy, drug and diagnostic development, and technology sectors contributed to the report, which builds on the vision for an early warning system as outlined in FasterCures June 2021 release, A Global Early Warning System for Pandemics: Mobilizing Surveillance for Emerging Pathogens .
  • The report highlights immediate next steps for mobilizing an early warning system and acknowledges that areas remain for ongoing deliberation.
  • A Global Early Warning System for Pandemics: A Blueprint for Coordination is co-authored by Esther Krofah, Sung Hee Choe, Alisha Sud, and Anna DeGarmo.

MEDIA ADVISORY: 2021 Milken Institute Partnering for Patients Forum to Feature Patient, Policy, and Industry Leaders

Retrieved on: 
Wednesday, December 1, 2021

As the COVID-19 pandemic consumes the worlds collective focus, patients continue to suffer from a variety of conditions.

Key Points: 
  • As the COVID-19 pandemic consumes the worlds collective focus, patients continue to suffer from a variety of conditions.
  • The 2021 Milken Institute Partnering for Patients Forum, December 6-7, will convene patient groups and industry leaders to discuss advancing desperately needed biomedical innovation and keeping patients at the center of research and development.
  • Led by FasterCures and the Milken Institute Center for Public Health, all public sessions will be virtual and live-streamed on the Milken Institute website.
  • Where: Virtual and In-Person | Washington, D.C.
    Subject matter experts from FasterCures and the Milken Institute Center for Public Health will be available for interview requests.

EQRx Appoints Kathy Giusti to Board of Directors

Retrieved on: 
Monday, September 27, 2021

EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced the appointment of Kathy Giusti to the Companys board of directors.

Key Points: 
  • EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced the appointment of Kathy Giusti to the Companys board of directors.
  • She was named to the Presidents Council of Advisors on Science and Technology (PCAST), the National Cancer Advisory Board (NCAB), and the National Cancer Policy Board (NCPB).
  • Kathy serves as a member of Verilys advisory board, the FasterCures Non-Profit Council and the Harvard Business School Health Advisory Board.
  • Neither EQRx nor CM Life Sciences III gives any assurance that either EQRx or CM Life Sciences III or the combined company will achieve its expectations.

Greg Simon to Present a Keynote Address at the AVBCC Summit

Retrieved on: 
Monday, August 30, 2021

CRANBURY, N.J., Aug. 30, 2021 /PRNewswire-PRWeb/ -- The Association for Value-Based Cancer Care ( AVBCC ) is pleased to announce the addition of Greg Simon, JD, Past President of the Biden Cancer Initiative, as a keynote speaker at the 11th AVBCC Summit & Educational Program.

Key Points: 
  • CRANBURY, N.J., Aug. 30, 2021 /PRNewswire-PRWeb/ -- The Association for Value-Based Cancer Care ( AVBCC ) is pleased to announce the addition of Greg Simon, JD, Past President of the Biden Cancer Initiative, as a keynote speaker at the 11th AVBCC Summit & Educational Program.
  • The AVBCC Summit will be taking place in New York, New York, on October 13-15, 2021, with a virtual simulcast option for those who cannot attend in person.
  • Mr Simon will be delivering the keynote address entitled Understanding How the Biden Administration Will Influence Policy and Shape Cancer Care into the Future at the AVBCC Summit.
  • TLG proudly serves as co-founder and association management company of the Academy of Oncology Nurse & Patient Navigators (AONN+) and the Association for Value-Based Cancer Care (AVBCC).

Milken Institute Urges Better Global Coordination to Detect and Prevent Future Pandemics

Retrieved on: 
Thursday, June 3, 2021

FasterCures, a center of the Milken Institute, today released a set of recommendations that can be used to mobilize an early warning system for global pandemic threats.

Key Points: 
  • FasterCures, a center of the Milken Institute, today released a set of recommendations that can be used to mobilize an early warning system for global pandemic threats.
  • The pandemic revealed significant gaps in early warning capabilities, but we now know what it will take to develop a better, more effective system.
  • Its now critically important to bring our efforts to scale through dedicated focus and close coordination to ensure global readiness to detect emerging threats to human health.
  • A Global Early Warning System for Pandemics: Mobilizing Surveillance for Emerging Pathogens is co-authored by Esther Krofah, Carly Gasca, and Anna DeGarmo.

Milken Institute Launches “Early Warning” Initiative for Emerging Pandemic Threats as COVID-19 Cases Increase

Retrieved on: 
Wednesday, December 2, 2020

FasterCures, a center of the Milken Institute devoted to accelerating biomedical innovation, today launched an initiative to build a global early warning system that detects and responds to emerging pathogens with pandemic potential.

Key Points: 
  • FasterCures, a center of the Milken Institute devoted to accelerating biomedical innovation, today launched an initiative to build a global early warning system that detects and responds to emerging pathogens with pandemic potential.
  • COVID-19 caught the world by surprise, and it shouldnt have, said Esther Krofah, Executive Director of FasterCures.
  • The current global infrastructure for pandemic preparedness suffers from deep fragmentation, lack of coordination, little global collaboration, and virtually no sustained governmental and organizational commitment.
  • FasterCures, a center of the Milken Institute, is working to build a system that is effective, efficient, and driven by a clear vision: patient needs above all else.

Engaging Diverse Patient Populations in Rare Disease Clinical Research, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, November 16, 2020

There are more than 2,500 gene-based therapies in the biotech pipeline, many of which are targeted for rare diseases.

Key Points: 
  • There are more than 2,500 gene-based therapies in the biotech pipeline, many of which are targeted for rare diseases.
  • Clinical trials for these emerging therapies typically target very small patient populations, leading to significant challenges in the identification and enrollment of qualified patient participants.
  • Success in rare disease clinical trial enrollment and retention necessitates expanded access, more inclusive outreach strategies, and technology-driven solutions.
  • For more information, or to register for this event, visit Engaging Diverse Patient Populations in Rare Genetic Disease Clinical Research.

Focused Ultrasound Foundation Board of Directors Adds Two Iconic Leaders

Retrieved on: 
Thursday, September 3, 2020

Their expertise will broaden the effectiveness of the board, as it works to expand the use of focused ultrasound for a wide variety of serious medical disorders.

Key Points: 
  • Their expertise will broaden the effectiveness of the board, as it works to expand the use of focused ultrasound for a wide variety of serious medical disorders.
  • One of its 10 centers,FasterCures, is a close partner of the Focused Ultrasound Foundation, each sharing in the effort to remove barriers to progress in medical research.
  • The Focused Ultrasound Foundation was created to improve the lives of millions of people worldwide by accelerating the development of this noninvasive technology.
  • Since its establishment in 2006, the Foundation has become the largest nongovernmental source of funding for focused ultrasound research.